FDA NDC Directory · JSON-LD · Markdown

Rufinamide

NDC 60687-824 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerAmerican Health Packaging
Marketing categoryAbbreviated NDA (generic) · App ANDA207363
Dosage form / routeSUSPENSION · ORAL
Active ingredientsRUFINAMIDE (40 mg/mL)
Marketing started20260106
Package count1

External sources

Source: openFDA. Public-domain (CC0).